1 - 25 of 85 results for author:"Crawford D." in Literature citations
Results Customize
› Repeat search in UniProtKB (394)
| The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis. Tan T.C., Crawford D.H., Franklin M.E., Jaskowski L.A., Macdonald G.A., Jonsson J.R., Watson M.J., Taylor P.J., Fletcher L.M. Liver Int. 32:1391-1399(2012) · Mapped (6) |
| Replication and characterisation of genetic variants in the fibrinogen gene cluster with plasma fibrinogen levels and haematological traits in the Third National Health and Nutrition Examination Survey. Jeff J.M., Brown-Gentry K., Crawford D.C. Thromb. Haemost. 107:458-467(2012) · Mapped (5) |
| Population differences in genetic risk for age-related macular degeneration and implications for genetic testing. Spencer K.L., Glenn K., Brown-Gentry K., Haines J.L., Crawford D.C. Arch. Ophthalmol. 130:116-117(2012) · Mapped (1) |
| A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes. Kaab S., Crawford D.C., Sinner M.F., Behr E.R., Kannankeril P.J., Wilde A.A., Bezzina C.R., Schulze-Bahr E., Guicheney P., Bishopric N.H. et al. Circ Cardiovasc Genet 5:91-99(2012) · Mapped (7) |
| Genetic variants associated with the white blood cell count in 13,923 subjects in the eMERGE Network. Crosslin D.R., McDavid A., Weston N., Nelson S.C., Zheng X., Hart E., de Andrade M., Kullo I.J., McCarty C.A., Doheny K.F. et al. Hum. Genet. 131:639-652(2012) · Mapped (46) |
| Identifying host genetic risk factors in the context of public health surveillance for invasive pneumococcal disease. Lingappa J.R., Dumitrescu L., Zimmer S.M., Lynfield R., McNicholl J.M., Messonnier N.E., Whitney C.G., Crawford D.C. PLoS ONE 6:e23413-e23413(2011) · Mapped (4) |
| Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis. Tan T.C., Crawford D.H., Jaskowski L.A., Murphy T.M., Heritage M.L., Subramaniam V.N., Clouston A.D., Anderson G.J., Fletcher L.M. Am. J. Physiol. Gastrointest. Liver Physiol. 301:G865-76(2011) · Mapped (5) |
| Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD. Clark W.B., Brown-Gentry K.D., Crawford D.C., Fan K.H., Snavely J., Chen H., Savani B.N., Kassim A., Greer J.P., Schuening F.G. et al. Blood 118:1140-1144(2011) · Mapped (5) |
| Ordered and dynamic assembly of single spliceosomes. Hoskins A.A., Friedman L.J., Gallagher S.S., Crawford D.J., Anderson E.G., Wombacher R., Ramirez N., Cornish V.W., Gelles J., Moore M.J. Science 331:1289-1295(2011) · Mapped (8) |
| SCN5A variation is associated with electrocardiographic traits in the Jackson Heart Study. Jeff J.M., Brown-Gentry K., Buxbaum S.G., Sarpong D.F., Taylor H.A., George A.L. Jr., Roden D.M., Crawford D.C. Circ Cardiovasc Genet 4:139-144(2011) · Mapped (14) |
| The chemokine receptor CXCR7 functions to regulate cardiac valve remodeling. Yu S., Crawford D., Tsuchihashi T., Behrens T.W., Srivastava D. |
| CXCR4 and CXCR7 have distinct functions in regulating interneuron migration. Wang Y., Li G., Stanco A., Long J.E., Crawford D., Potter G.B., Pleasure S.J., Behrens T., Rubenstein J.L. Neuron 69:61-76(2011) · Mapped (1) |
| Inducible COX-2-dependent apoptosis in human ovarian cancer cells. Lin C., Crawford D.R., Lin S., Hwang J., Sebuyira A., Meng R., Westfall J.E., Tang H.Y., Lin S., Yu P.Y. et al. Carcinogenesis 32:19-26(2011) · Mapped (5) |
| Soluble CD30: a serum marker for Epstein-Barr virus-associated lymphoproliferative diseases. Haque T., Chaggar T., Schafers J., Atkinson C., McAulay K.A., Crawford D.H. J. Med. Virol. 83:311-316(2011) · Mapped (5) |
| VKORC1 common variation and bone mineral density in the Third National Health and Nutrition Examination Survey. Crawford D.C., Brown-Gentry K., Rieder M.J. PLoS ONE 5:e15088-e15088(2010) · Mapped (2) |
| Myocardial dysfunction in an animal model of cancer cachexia. Xu H., Crawford D., Hutchinson K.R., Youtz D.J., Lucchesi P.A., Velten M., McCarthy D.O., Wold L.E. Life Sci. 88:406-410(2011) · Mapped (1) |
| The calcineurin inhibitor RCAN1 is involved in cultured macrophage and in vivo immune response. Bhoiwala D.L., Kannabiran V., Hushmendy S.F., Hahn A., Bhoiwala D.L., Heuring J.M., Crawford D.R. FEMS Immunol. Med. Microbiol. 61:103-113(2011) · Mapped (3) |
| Identification of genomic predictors of atrioventricular conduction: using electronic medical records as a tool for genome science. Denny J.C., Ritchie M.D., Crawford D.C., Schildcrout J.S., Ramirez A.H., Pulley J.M., Basford M.A., Masys D.R., Haines J.L., Roden D.M. Circulation 122:2016-2021(2010) · Mapped (1) |
| Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection. Grebely J., Petoumenos K., Hellard M., Matthews G.V., Suppiah V., Applegate T., Yeung B., Marks P., Rawlinson W., Lloyd A.R. et al. Hepatology 52:1216-1224(2010) · Mapped (1) |
| Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. Ritchie M.D., Denny J.C., Crawford D.C., Ramirez A.H., Weiner J.B., Pulley J.M., Basford M.A., Brown-Gentry K., Balser J.R., Masys D.R. et al. Am. J. Hum. Genet. 86:560-572(2010) · Mapped (25) |
| PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Denny J.C., Ritchie M.D., Basford M.A., Pulley J.M., Bastarache L., Brown-Gentry K., Wang D., Masys D.R., Roden D.M., Crawford D.C. Bioinformatics 26:1205-1210(2010) · Mapped (306) |
| Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups. International Warfarin Pharmacogenetics Consortium Blood 115:3827-3834(2010) · Mapped (2) |
| CRP polymorphisms and progression of chronic kidney disease in African Americans. Hung A.M., Crawford D.C., Griffin M.R., Brown-Gentry K., Lipkowitz M.S., Siew E.D., Cavanaugh K., Lewis J.B., Ikizler T.A. Clin J Am Soc Nephrol 5:24-33(2010) · Mapped (2) |
| Glutathione-S-transferase A3 knockout mice are sensitive to acute cytotoxic and genotoxic effects of aflatoxin B1. Ilic Z., Crawford D., Vakharia D., Egner P.A., Sell S. Toxicol. Appl. Pharmacol. 242:241-246(2010) · Mapped (7) |
| Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease. McAulay K.A., Haque T., Crawford D.H. Br. J. Cancer 101:1019-1027(2009) · Mapped (56) |